Cardiovascular Medicine and Haematology articles for Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), China

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 64

Article ‘Count’ for Cardiovascular Medicine and Haematology.

Journal Count Share
2 0.34
In Vivo Immunomodulatory Programming of Circulating Myeloid Cells via Itaconic Acid Liposomes to Mitigate Myocarditis 0.26
Targeting Senescent Alveolar Type 2 Cells with a Gene-Editable FePt Dual-Atom Catalyst for Mitigating Idiopathic Pulmonary Fibrosis 0.08
1 1.00
Nanoparticles coated with immune cell hybrid membranes for targeted delivery of janus kinase inhibitors and synergistic treatment of autoimmune myocarditis 1.00
1 0.79
The Current Status of Cardiac Rehabilitation in China: A Cross-sectional National Survey 0.79
1 0.03
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia 0.03
1 0.89
Targeting lysozyme 2 in endocardium promotes rapid recovery by modulating remote injury signals 0.89
3 2.10
Rare variants in PAH-related genes associate with a distinct vasculopathy phenotype and worse outcomes in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension 0.98
Developing and Validation of a Multimodal-based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia: a Prospective Multicenter Study 0.23
Deep Learning-Enhanced Non-Invasive Detection of Pulmonary Hypertension and Subtypes via Chest Radiographs, Validated by Catheterization 0.89
5 1.68
GPRASP1 Safeguards Endothelial Aspartate Metabolism to Prevent Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. 0.95
Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial. 0.01
CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy 0.30
Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial. 0.38
TAX1BP3 Is a SUMOylated Nucleocytoplasmic Shuttling Protein and Protects Against Vascular Neointimal Hyperplasia. 0.05
1 0.22
Impact of Ambient Ozone Exposure on Cardiac Biomarkers in Heart Failure and the Role of Sodium-glucose Cotransporter-2 Inhibitors: Findings from the TRACER-HF Trial 0.22
5 2.64
Frozen elephant trunk for acute type A aortic dissection: long-term outcomes over two decades 0.15
Left bundle branch vs biventricular pacing: mechanistic insights from a canine model 0.58
Oestrogen-related receptor γ in sepsis-induced cardiomyopathy: role of cardiomyocyte subtype conversion 0.07
Endothelial plasticity in atrial fibrosis by integrating single-cell sequencing and genetic lineage tracing 0.98
Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial 0.86
2 0.34
Bioresorbable vs Metallic Occluders for Transcatheter Atrial Septal Defect Closure 0.29
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps 0.05
1 0.17
Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis 0.17
2 0.09
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. 0.04
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321). 0.04
1 0.65
Heterozygous human JAK2V617F activates AhR to drive essential thrombocythemia and promote thrombosis 0.65
3 2.89
Posterior wall thickness associates with outcomes after septal myectomy in childhood hypertrophic obstructive cardiomyopathy——original article 0.89
Totally thoracoscopic transmitral versus transaortic septal myectomy for hypertrophic cardiomyopathy: A propensity score−matched comparative study 1.00
Reversed septal motion in congenital corrected transposition of the great arteries: A potential mechanism for tricuspid regurgitation 1.00
10 4.05
Blood Pressure Trajectories and Cardiovascular Outcomes in Older Patients 0.07
Achieving Intensive Blood Pressure Control in High-Risk Patients: Implementation Insights From the ESPRIT Trial 0.40
Real-Time Heart Team for Revascularization in Complex Coronary Artery Disease 0.87
Effect of Baduanjin on Blood Pressure Among Individuals With High-Normal Blood Pressure: A Multicenter, Open-Label, Blinded-Outcome Randomized Controlled Trial 0.48
Pulsed Field Ablation Using a Novel Biphasic Catheter vs Thermal Ablation for Paroxysmal Atrial Fibrillation InsightPFA Trial 0.08
Modest Effects of Intensive Blood Pressure–Lowering on Quality of Life in Patients at High Cardiovascular Risk The ESPRIT Trial 0.59
Intensive Blood Pressure Control in Older Patients With Hypertension 6-Year Results of the STEP Trial 0.23
Effects of Intensive Blood Pressure Control in Patients With Frailty A Post Hoc Analysis From ESPRIT 0.46
LDL-C related cardiovascular burden in China 2010-2030: Spatiotemporal patterns and scenario-based projections 0.58
Effect of Intensive Blood Pressure Control on Stroke A Prespecified Secondary Analysis of the ESPRIT Trial 0.29
9 2.36
Restoration of RBM22 overcomes the transcriptional and epigenetic barriers of cardiomyocyte proliferation for heart regeneration 0.04
Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling 0.28
Gut microbiota-derived metabolite isovalerylcarnitine modulates salt sensitivity of blood pressure and incident hypertension: a multicenter dietary salt intervention trial 0.67
Deciphering age- and sex-specific patterns of coronary artery atherosclerosis from a large Chinese cohort 0.08
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trial 0.04
Lymph nodes molecular subtypes unravel lymph nodes heterogeneity and clinical implications in colorectal cancer 0.49
Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy 0.22
A programmable platelet theranostic platform for adaptive multi-stage delivery and synergistic immunotherapy in atherosclerosis 0.28
Stress granule assembly impairs macrophage efferocytosis to aggravate allergic rhinitis in mice 0.26
3 0.10
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial 0.03
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study 0.00
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial 0.07
1 0.98
Genome-wide analysis identifies susceptibility loci for heart failure and nonischemic cardiomyopathy subtype in the East Asian populations 0.98
1 0.24
Calumenin prevents fibroblast senescence and lung aging by promoting vimentin proteostasis 0.24
2 0.91
Super-Resolution Deep Learning Reconstruction for Coronary CT Angiography: Coronary Stenosis Assessment and CAD-RADS Reclassification. 0.13
Right Ventricular Strain Improves Cardiac MRI-based Prognostication in Heart Failure with Preserved Ejection Fraction. 0.79
2 1.22
Efficacy of dual antiplatelet therapy for three months versus 12 months after coronary artery bypass grafting: multicentre, double blinded, randomised controlled trial 0.57
Impact of shifting blood donation policy from gift to honour model: staggered difference-in-differences analysis in China 0.65
4 0.12
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial 0.00
Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-blind, randomised trial 0.02
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation study 0.02
Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials 0.08
1 0.05
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial 0.05
2 0.62
Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease 0.02
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia 0.60

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.